FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082559972> ?p ?o ?g. }

• W2082559972 endingPage "602" @default.
• W2082559972 startingPage "596" @default.
• W2082559972 abstract "Cefotaxime is considered the first-choice antibiotic for empirical treatment in cirrhotic patients developing bacterial infections. It has been suggested that amoxicillin-clavulanic acid could be an alternative to cefotaxime, particularly in patients developing bacterial infections while on prophylactic norfloxacin. The aim of the present study was to compare amoxicillin-clavulanic acid with cefotaxime in the treatment of bacterial infections in cirrhosis.Ninety-six hospitalized cirrhotic patients with suspicion of bacterial infection were prospectively included and randomized into two groups: one group (n=48) received amoxicillin-clavulanic acid, first intravenously 1 g-0.2 g every 8 h, and then orally 500 mg-125 mg every 8 h, and the other group (n=48) received intravenous cefotaxime 1 g every 6 h. Patients were stratified for previous prophylaxis with norfloxacin and ascitic fluid infection.Sixteen patients were excluded from the analysis because bacterial infection was not demonstrated or because of secondary peritonitis. Therefore, 38 patients from the amoxicillin-clavulanic acid group and 42 from the cefotaxime group were finally analyzed. There were 24 ascitic fluid infections in each group. Infection resolution (86.8% vs 88%, 95% CI: -0.15 to 0.13, p NS), spontaneous bacterial peritonitis resolution (87.5% vs 83.3%, 95% CI: -0.15 to 0.24, p NS), duration of treatment, incidence of complications, time of hospitalization and hospital mortality were similar in both groups. Considering patients on prophylactic norfloxacin, infection resolution was also similar (100% vs 83.3%, 95% CI: -0.04 to 0.37, p NS). No adverse events were observed in either of the two groups. The cost of antibiotics was statistically lower in the amoxicillin-clavulanic acid group (p<0.001).Amoxicillin-clavulanic acid is as effective as cefotaxime in the treatment of bacterial infections in cirrhotic patients, but is less expensive and can be administered orally. These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment of bacterial infections in cirrhosis." @default.
• W2082559972 created "2016-06-24" @default.
• W2082559972 creator A5018030848 @default.
• W2082559972 creator A5021437766 @default.
• W2082559972 creator A5026828773 @default.
• W2082559972 creator A5030308842 @default.
• W2082559972 creator A5030817055 @default.
• W2082559972 creator A5034682808 @default.
• W2082559972 creator A5038984009 @default.
• W2082559972 creator A5051374525 @default.
• W2082559972 creator A5054128014 @default.
• W2082559972 creator A5056219801 @default.
• W2082559972 creator A5062131836 @default.
• W2082559972 creator A5078892003 @default.
• W2082559972 date "2000-04-01" @default.
• W2082559972 modified "2023-10-18" @default.
• W2082559972 title "Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients" @default.
• W2082559972 cites W1503233297 @default.
• W2082559972 cites W1589998414 @default.
• W2082559972 cites W1608294118 @default.
• W2082559972 cites W1844667197 @default.
• W2082559972 cites W1964452095 @default.
• W2082559972 cites W1969597930 @default.
• W2082559972 cites W1996461070 @default.
• W2082559972 cites W2003186526 @default.
• W2082559972 cites W2008725020 @default.
• W2082559972 cites W2012654744 @default.
• W2082559972 cites W2012842560 @default.
• W2082559972 cites W2019679665 @default.
• W2082559972 cites W2019725352 @default.
• W2082559972 cites W2020624820 @default.
• W2082559972 cites W2030089895 @default.
• W2082559972 cites W2030845984 @default.
• W2082559972 cites W2057575003 @default.
• W2082559972 cites W2064182480 @default.
• W2082559972 cites W2068012034 @default.
• W2082559972 cites W2083396354 @default.
• W2082559972 cites W2094136578 @default.
• W2082559972 cites W2102722043 @default.
• W2082559972 cites W2106227553 @default.
• W2082559972 cites W2151039065 @default.
• W2082559972 cites W2158011824 @default.
• W2082559972 cites W2166480976 @default.
• W2082559972 cites W2592807021 @default.
• W2082559972 doi "https://doi.org/10.1016/s0168-8278(00)80221-4" @default.
• W2082559972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10782908" @default.
• W2082559972 hasPublicationYear "2000" @default.
• W2082559972 type Work @default.
• W2082559972 sameAs 2082559972 @default.
• W2082559972 citedByCount "148" @default.
• W2082559972 countsByYear W20825599722012 @default.
• W2082559972 countsByYear W20825599722013 @default.
• W2082559972 countsByYear W20825599722014 @default.
• W2082559972 countsByYear W20825599722015 @default.
• W2082559972 countsByYear W20825599722016 @default.
• W2082559972 countsByYear W20825599722017 @default.
• W2082559972 countsByYear W20825599722018 @default.
• W2082559972 countsByYear W20825599722019 @default.
• W2082559972 countsByYear W20825599722020 @default.
• W2082559972 countsByYear W20825599722021 @default.
• W2082559972 countsByYear W20825599722023 @default.
• W2082559972 crossrefType "journal-article" @default.
• W2082559972 hasAuthorship W2082559972A5018030848 @default.
• W2082559972 hasAuthorship W2082559972A5021437766 @default.
• W2082559972 hasAuthorship W2082559972A5026828773 @default.
• W2082559972 hasAuthorship W2082559972A5030308842 @default.
• W2082559972 hasAuthorship W2082559972A5030817055 @default.
• W2082559972 hasAuthorship W2082559972A5034682808 @default.
• W2082559972 hasAuthorship W2082559972A5038984009 @default.
• W2082559972 hasAuthorship W2082559972A5051374525 @default.
• W2082559972 hasAuthorship W2082559972A5054128014 @default.
• W2082559972 hasAuthorship W2082559972A5056219801 @default.
• W2082559972 hasAuthorship W2082559972A5062131836 @default.
• W2082559972 hasAuthorship W2082559972A5078892003 @default.
• W2082559972 hasConcept C126322002 @default.
• W2082559972 hasConcept C141071460 @default.
• W2082559972 hasConcept C2776205632 @default.
• W2082559972 hasConcept C2777214474 @default.
• W2082559972 hasConcept C2777364826 @default.
• W2082559972 hasConcept C2778512257 @default.
• W2082559972 hasConcept C2778719061 @default.
• W2082559972 hasConcept C2778746504 @default.
• W2082559972 hasConcept C2779454058 @default.
• W2082559972 hasConcept C2779708577 @default.
• W2082559972 hasConcept C501593827 @default.
• W2082559972 hasConcept C71924100 @default.
• W2082559972 hasConcept C86803240 @default.
• W2082559972 hasConcept C89423630 @default.
• W2082559972 hasConcept C90924648 @default.
• W2082559972 hasConceptScore W2082559972C126322002 @default.
• W2082559972 hasConceptScore W2082559972C141071460 @default.
• W2082559972 hasConceptScore W2082559972C2776205632 @default.
• W2082559972 hasConceptScore W2082559972C2777214474 @default.
• W2082559972 hasConceptScore W2082559972C2777364826 @default.
• W2082559972 hasConceptScore W2082559972C2778512257 @default.
• W2082559972 hasConceptScore W2082559972C2778719061 @default.
• W2082559972 hasConceptScore W2082559972C2778746504 @default.
• W2082559972 hasConceptScore W2082559972C2779454058 @default.

• next